Myofibroblasts and the progression of diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 12, Issue 1, 1997, Pages 43-50

  Essawy, M ^a   Soylemezoglu, O ^a   Muchaneta Kubara, E C ^a   Shortland, J ^a   Brown, C B ^a   El Nahas, A M ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

smooth muscle actin; Desmin; Diabetic nephropathy; Myofibroblasts; Vimentin

Indexed keywords

ALPHA ACTIN; CYTOSKELETON PROTEIN; DESMIN; VIMENTIN;

ADOLESCENT; ADULT; ADVENTITIA; AGED; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLOMERULUS EPITHELIUM; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MYOFIBROBLAST; NEPHROSCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; TUNICA MEDIA;

ACTINS; ADOLESCENT; ADULT; AGED; CYTOSKELETAL PROTEINS; DESMIN; DIABETIC NEPHROPATHIES; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MIDDLE AGED; PROGNOSIS; VIMENTIN;

EID: 0031013910     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.1.43     Document Type: Article

References (27)

1. Ziyadeh FN, Goldfarb S, Kern EFO. Diabetic nephropathy: metabolic and biochemical mechanisms. In: Brenner BM, Stein JH, eds. The Kidney in Diabetes Mellitus. Churchill Livingstone, New York, 1989; 20: 87-113
2. Breyer JA. Diabetic nephropathy in insulin-dependent patients. Am J Kidney Dis 1992; 20: 533-547
3. Ziyadeh FN, Goldfarb S. The renal tubulointerstitium in diabetes mellitus. Kidney Int 1991; 39: 464-475
4. Steffes MW, Osterby R, Chavers B, Mauer M. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989; 38: 1077-1081
5. Bader R, Bader H, Grund KE, Mackensen-Haen S, Christ H, Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis. Pathol Res Pract 1980; 1 67: 204-216
6. Gabbiani G. The biology of the myofibroblasts. Kidney Int 1992; 41 : 530-532
7. Sehmitt-Graff A, Desmouliere A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Archiv 1994; 425: 3-24
8. Sappino A-P, Schurch W, Gabbiani G. Differentiation of fibroblastie cells: expression of cytoskeletal proteins as marker of phenotypic modulation. Lab Invest 1990; 63: 144-161
9. Johnson RI, Ida H, Alpers C et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: α-smooth-muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991; 87: 847-858
10. Zhang G, Moorhead PJ, El Nahas AM. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995; 3: 308-318
11. Alpers CE, Hudkins KL, Gown AM, Johnson RJ. Enhanced expression of 'muscle-specific' actin in glomerulonephritis.Kidney Int 1992; 41: 1134-1142
12. Goumenos D, Brown CB, Shortland J, El Nahas AM. Myofibroblasts and the progression of mesangial IgA nephropathy. Nephrol Dial Transplant 1994; 9: 1418-1425
13. El Nahas AM, Muchaneta-Kubara EC, Zhang G, Adam A, Goumenos D. Phenotypic changes in the pathogenesis of renal scarring. Kidney Int 1996; 49 [Suppl 54]: S23-S27
14. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth-muscle actin: a new probe for smooth muscle cell differentiation. J Cell Biol 1986; 103: 2787-2796
15. Nouwen EJ, Verstrepen WA, Buyssens N, Zhu M-Q, De Broe M. Hyperplasia, hypertrophy and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab Invest 1994; 70: 479-493
16. Johnson RJ, Alpers CE, Yoshimura A et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464-474
17. Young BA, Johnson RJ, Alpers CE et al. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 1995; 47: 935-944
18. Stamenkovic I, Skalli O, Gabbiani G. Distribution of intermediate filament proteins in normal and diseased human glomeruli. Am J Pathol 1986; 125: 465-475
19. Strutz F, Caron P, Tomaszewski I, Fumo P, Ziyadch F, Neilson EG. Transdifferentiation: a new concept in renal fibrogenesis. J Am Soc Nephrol 1994; 5: 819
20. Grone H-J, Weber K, Grone E, Helmchen U, Osborn M. Coexpression of keratin and vimentin in damaged and regenerating tubular epithelial of the kidney.Am J Pathol 1987; 129: 1-8
21. Strutz F. The fibroblast - (a (trans-) differentiated cell? Nephrol Dial Transplant 1995; 10: 1504-1506
22. Yaoita E, Kawasaki K, Yamamoto T, Kihara I. Variable expression of desmin in rat glomerular epithelial cells. Am J Pathol 1990; 136: 899-908
23. Adam A, Goumenos D, Brown CB, Shortland J, El Nahas AM. Phenotypic modulation of renal cells in the course of mesangiocapillary glomerulonephritis (MCGN). J Am Soc Nephrol 1995; 6: 1008
24. Muchaneta-Kubara EC, El Nahas AM. Transdifferentiation of renal cells during experimental renal scarring. J Am Soc Nephrol 1995; 6: 903
25. Desmouliere A, Geinoz A, Gabbiani F, Gabbianin G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent growing fibroblasts. J Cell Biol 1993; 122: 1103-1111
26. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 1992; 41: 107-114
27. Yamamoto T, Nakamura T, Noble AA, Ruoslahti E, Border WA. Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993; 90: 1814-1818